Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory sync... Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Mehr anzeigen
Mr. Finney brings 35 years of leadership, operations and corporate development experience SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the...
COVID-19 Phase 2b study poised to initiate 10,000 participant portion of trial pending U.S. Food and Drug Administration (FDA) review of sentinel cohort 30-day safety data Norovirus program to...
Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without modifications based on initial safety assessment of 400 participant 30-day data The company plans to progress...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0252 | 3.52447552448 | 0.715 | 0.779 | 0.65 | 975245 | 0.71636413 | CS |
| 4 | -0.0763 | -9.3447642376 | 0.8165 | 0.85 | 0.65 | 1214782 | 0.74316319 | CS |
| 12 | 0.0527 | 7.66545454545 | 0.6875 | 0.9799 | 0.5347 | 1807198 | 0.69641064 | CS |
| 26 | 0.1252 | 20.3577235772 | 0.615 | 1.07 | 0.5347 | 1765696 | 0.76683032 | CS |
| 52 | -0.4198 | -36.1896551724 | 1.16 | 1.54 | 0.52 | 2299492 | 0.78632468 | CS |
| 156 | -4.0398 | -84.5146443515 | 4.78 | 5.43 | 0.52 | 2198481 | 1.68370883 | CS |
| 260 | -0.2998 | -28.8269230769 | 1.04 | 24.9 | 0.52 | 6683287 | 6.80177355 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
